417 related articles for article (PubMed ID: 18980922)
1. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
Myers JS; Pierce J; Pazdernik T
Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the theory of unpleasant symptoms and the conceptual model of chemotherapy-related changes in cognitive function.
Myers JS
Oncol Nurs Forum; 2009 Jan; 36(1):E1-10. PubMed ID: 19136326
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms.
Myers JS
Oncol Nurs Forum; 2008 Sep; 35(5):802-7. PubMed ID: 18765326
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-related change in cognitive function: a conceptual model.
Hess LM; Insel KC
Oncol Nurs Forum; 2007 Sep; 34(5):981-94. PubMed ID: 17878127
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms for chemotherapy-induced impairments in cognitive function.
Jansen C; Miaskowski C; Dodd M; Dowling G; Kramer J
Oncol Nurs Forum; 2005 Nov; 32(6):1151-63. PubMed ID: 16270111
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-related cognitive impairment.
Myers JS
Clin J Oncol Nurs; 2009 Aug; 13(4):413-21. PubMed ID: 19648097
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research.
Seigers R; Fardell JE
Neurosci Biobehav Rev; 2011 Jan; 35(3):729-41. PubMed ID: 20869395
[TBL] [Abstract][Full Text] [Related]
9. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
Vardy J; Rourke S; Tannock IF
J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
Saykin AJ; Ahles TA; McDonald BC
Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
Tannock IF; Ahles TA; Ganz PA; Van Dam FS
J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
15. Renaming "chemobrain".
Hurria A; Somlo G; Ahles T
Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-related cognitive change: a principle-based concept analysis.
Kanaskie ML
Oncol Nurs Forum; 2012 May; 39(3):E241-8. PubMed ID: 22543395
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of paclitaxel treatment on cognitive functioning and mechanical sensitivity.
Boyette-Davis JA; Fuchs PN
Neurosci Lett; 2009 Apr; 453(3):170-4. PubMed ID: 19429028
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.
Wood LJ; Nail LM; Gilster A; Winters KA; Elsea CR
Oncol Nurs Forum; 2006 May; 33(3):535-42. PubMed ID: 16676010
[TBL] [Abstract][Full Text] [Related]
19. Cancer, cognitive impairment, and meditation.
Biegler KA; Chaoul MA; Cohen L
Acta Oncol; 2009; 48(1):18-26. PubMed ID: 19031161
[TBL] [Abstract][Full Text] [Related]
20. Cognitive function after chemotherapy in adults with solid tumours.
Vardy J; Tannock I
Crit Rev Oncol Hematol; 2007 Sep; 63(3):183-202. PubMed ID: 17678745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
